Cargando…

Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system

BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorniani, Dena, Hussein, Mohd Zobir bin, Kura, Aminu Umar, Fakurazi, Sharida, Shaari, Abdul Halim, Ahmad, Zalinah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791920/
https://www.ncbi.nlm.nih.gov/pubmed/24106420
http://dx.doi.org/10.2147/DDDT.S43035
_version_ 1782286772475002880
author Dorniani, Dena
Hussein, Mohd Zobir bin
Kura, Aminu Umar
Fakurazi, Sharida
Shaari, Abdul Halim
Ahmad, Zalinah
author_facet Dorniani, Dena
Hussein, Mohd Zobir bin
Kura, Aminu Umar
Fakurazi, Sharida
Shaari, Abdul Halim
Ahmad, Zalinah
author_sort Dorniani, Dena
collection PubMed
description BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types of drugs. METHODS AND RESULTS: We synthesized superparamagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. Fourier transform infrared spectra confirmed that these Fe(3)O(4) nanoparticles could be successfully coated with active drug, and thermogravimetric and differential thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The synthesized Fe(3)O(4) nanoparticles and the FCMP nanocomposite were generally spherical, with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. In order to improve drug loading and release behavior, we prepared a novel nanocomposite (FCMP-D), ie, Fe(3)O(4) nanoparticles containing the same amounts of chitosan and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did not demonstrate “burst release” and the maximum percentage release of 6-mercaptopurine from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse fibroblast cell line. CONCLUSION: Iron oxide coated with chitosan containing 6-mercaptopurine prepared using a coprecipitation method has the potential to be used as a controlled-release formulation. These nanoparticles may serve as an alternative drug delivery system for the treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue.
format Online
Article
Text
id pubmed-3791920
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37919202013-10-08 Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system Dorniani, Dena Hussein, Mohd Zobir bin Kura, Aminu Umar Fakurazi, Sharida Shaari, Abdul Halim Ahmad, Zalinah Drug Des Devel Ther Original Research BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types of drugs. METHODS AND RESULTS: We synthesized superparamagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. Fourier transform infrared spectra confirmed that these Fe(3)O(4) nanoparticles could be successfully coated with active drug, and thermogravimetric and differential thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The synthesized Fe(3)O(4) nanoparticles and the FCMP nanocomposite were generally spherical, with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. In order to improve drug loading and release behavior, we prepared a novel nanocomposite (FCMP-D), ie, Fe(3)O(4) nanoparticles containing the same amounts of chitosan and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did not demonstrate “burst release” and the maximum percentage release of 6-mercaptopurine from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse fibroblast cell line. CONCLUSION: Iron oxide coated with chitosan containing 6-mercaptopurine prepared using a coprecipitation method has the potential to be used as a controlled-release formulation. These nanoparticles may serve as an alternative drug delivery system for the treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue. Dove Medical Press 2013-09-25 /pmc/articles/PMC3791920/ /pubmed/24106420 http://dx.doi.org/10.2147/DDDT.S43035 Text en © 2013 Dorniani et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Dorniani, Dena
Hussein, Mohd Zobir bin
Kura, Aminu Umar
Fakurazi, Sharida
Shaari, Abdul Halim
Ahmad, Zalinah
Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title_full Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title_fullStr Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title_full_unstemmed Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title_short Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
title_sort preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791920/
https://www.ncbi.nlm.nih.gov/pubmed/24106420
http://dx.doi.org/10.2147/DDDT.S43035
work_keys_str_mv AT dornianidena preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem
AT husseinmohdzobirbin preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem
AT kuraaminuumar preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem
AT fakurazisharida preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem
AT shaariabdulhalim preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem
AT ahmadzalinah preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem